youtube_live
Q2 2027 earnings • released • EPS beat +20,18% • Revenue beat +9,66%
See resultschevron_right
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 520,00 ₹
arrow_downward
-2,14%(-55,10) 1D
4 նոյ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 625,50 ₹
High
2 625,50 ₹
Low
2 495,00 ₹
Mkt. cap
427,69 մլրդ
Avg. vol.
62,74 հզր
Volume
212,24 հզր
Dividend
2,26%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,97
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 625,50 ₹
High
2 625,50 ₹
Low
2 495,00 ₹
Mkt. cap
427,69 մլրդ
Avg. vol.
62,74 հզր
Volume
212,24 հզր
Dividend
2,26%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,97
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
kalkine.ca
·
20 րոպե առաջ
Is the Momentum Real in These Top 5 Highs: American Financial Group (NYSE:AFG), Andersen Group (NYSE:ANDG), Avidbank Holdings (NASDAQ:AVBH), Alerus Financial (NASDAQ:ALRS) or ACCO Brands (NYSE:ACCO)?
ABC7 Los Angeles
·
24 րոպե առաջ
Dow surges 1,000 points as Democrats take control of Congress
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd